Exploratory Clinical Study to Evaluation of the Safety and Immunogenicity of Bivalent Vaccine V-01D-351

NCT05583357 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Pandemic

Interventions

BIOLOGICAL: V-01D-351
BIOLOGICAL: V-01D-351
BIOLOGICAL: CoronaVac
BIOLOGICAL: CoronaVac

Sponsor

Livzon Pharmaceutical Group Inc.